Showing posts with label SGLT2-mediated renal glucose reabsorption; type 2 diabetes mellitus (T2DM). Show all posts
Showing posts with label SGLT2-mediated renal glucose reabsorption; type 2 diabetes mellitus (T2DM). Show all posts
Sunday, September 9, 2012

Lexicon announces results from two initial trials of LX4211 for type 2 diabetes

›
T hirty-six patients with type 2 diabetes mellitus (T2DM) were randomized 1:1:1 to receive a once-daily oral dose of placebo or 150 or 300...